Once considered mainly an afterthought in a company's lifecyde-management strategy, controlled-release dosage forms are now positioned at the forefront of many formulation strategies.
» more |
An emerging family of biotech drugs promises to revolutionize the treatment of life-threatening diseases. "Antisense" drugs work at the molecular level by binding to messenger.
» more |